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ABSTRACT 20 
It was recently reported that 44% of healthy humans in a study cohort had DNA 21 
sequences similar to Chlorovirus ATCV-1 (family Phycodnaviridae) in oropharyngeal 22 
samples and had decreases in visual processing and visual motor speed compared with 23 
individuals in whom no virus was detected.  Moreover, mice inoculated orally with 24 
ATCV-1 developed immune responses to ATCV-1 proteins and had decreases in 25 
certain cognitive domains.  Because heightened IL-6, nitric oxide (NO), and ERK MAP-26 
kinase activation from macrophages are linked to cognitive impairments, we evaluated 27 
cellular responses and viral plaque forming units in murine RAW264.7 and primary 28 
macrophages after exposure to ATCV-1 in vitro for up to 72 h after virus challenge. 29 
Approximately 8% of the ATCV-1 inoculum was associated with macrophages after 1 h 30 
and increased 2-3 fold over 72 h.  Immunoblots using rabbit anti-ATCV-1 detected a 55 31 
kDa protein consistent with viral capsid protein from 1 to 72 h and an increasing de 32 
novo synthesis of a previously unidentified 17 kDa protein beginning at 24 h.  33 
Emergence of the 17 kDa protein did not occur and persistence of the 55 kDa protein 34 
declined over time when cells were exposed to heat-inactivated ATCV-1.  Moreover, 35 
starting at 24 h, RAW264.7 cells exhibited cytopathic effects, Annexin V staining and 36 
cleaved-caspase 3.  Activation of ERK MAP-kinases occurred in these cells by 30 min 37 
post challenge, which preceded expression of IL-6 and NO.  Therefore ATCV-1 38 
persistence in and induction of inflammatory factors by these macrophages may 39 
contribute to declines in cognitive abilities of mice and humans.   40 
 41 
 42 
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Importance 43 
Virus infections that persist in and stimulate inflammatory factors from macrophages 44 
contribute to pathologies in humans.  A previous study showed that DNA sequences 45 
homologous to Chlorovirus ATCV-1 were found in a significant fraction of oropharyngeal 46 
samples from a healthy human cohort.  We show here unexpectedly that ATCV-1, 47 
whose only known host is an eukaryotic green alga (Chlorella heliozoae) that is an 48 
endosymbiont of the heliozoon Acanthocystis turfacea, can persist within murine 49 
macrophages and trigger inflammatory responses, including factors that contribute to 50 
immunopathologies. The inflammatory factors that are produced in response to ATCV-1 51 
include IL-6 and nitric oxide whose inductions are preceded by activation of ERK MAP-52 
kinases.  Other responses of ATCV-1-challenged macrophages include an apoptotic 53 
cytopathic effect, an innate anti-viral response, and a metabolic shift towards aerobic 54 
glycolysis.  Therefore, mammalian encounters with chloroviruses may contribute to 55 
chronic inflammatory responses from macrophages.  56 
  57 
  
4
Introduction 58 
Chloroviruses (family Phycodnaviridae) were discovered over 35 years ago and are 59 
distinctive because they are large icosahedral dsDNA viruses that infect certain 60 
unicellular eukaryotic green algae, which are themselves endosymbionts within protists 61 
(1).  Chloroviruses are classified based upon the algal species they infect.  NC64A 62 
viruses infect Chlorella variabilis NC64A from Paramecium bursaria, Pbi viruses infect 63 
Micractinium conductrix Pbi from Paramecium bursaria, Hydra viruses infect Chlorella 64 
species from Hydra viridis, and SAG viruses infect Chlorella heliozoae SAG 3.83 from 65 
the heliozoon Acanthocystis turfacea.  Chloroviruses have large linear 290 to 370 kbp 66 
dsDNA genomes that encode as many as 400 proteins. Chlorovirus  ATCV-1 is the type 67 
SAG 3.83 virus (2, 3).   Considerable information is available on the interaction of the 68 
chloroviruses with algae; however, nothing is known about their possible interaction with 69 
mammalian cells.  This possible interaction is relevant because a recent report indicated 70 
that ATCV-1-like DNA sequences were present in 44% of oropharyngeal samples from 71 
a healthy human cohort (4).  Moreover, the presence of ATCV-1 DNA in this cohort was 72 
correlated with decreased performance on certain cognitive tests. Experimental mice 73 
exposed by gavage to ATCV-1-infected C. heliozoae also exhibited significant cognitive 74 
impairments, specifically in recognition memory and sensory-motor gating, which was 75 
associated with significant changes in expression of 1,285 genes in the hippocampus, 76 
many of which are associated with immune and inflammatory responses.   Therefore, 77 
inflammatory responses to ATCV-1 may be associated with decreases in hippocampus 78 
activity that is needed for spatial recognition memory (5).   79 
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Several inflammatory events and mediators are known to affect the health of the 80 
central nervous system.  During certain viral infections inflammatory macrophages are 81 
involved in hippocampal damage (6, 7, 8, 9).   Interleukin-6 (IL-6) produced from many 82 
cell types including inflammatory macrophages is correlated with decreased 83 
hippocampus volume during depression (10), decreased learning (11, 12), impaired 84 
spatial learning and affects at the hippocampus (13). Nitric oxide (NO) produced by 85 
macrophages during inflammation is also associated with memory impairments (14).  86 
Therefore, ATCV-1 induction of inflammatory macrophages and mediators may be 87 
related to certain memory impairments.   88 
However, it is unknown if macrophages can become infected and/or respond to 89 
challenges with ATCV-1, or if ATCV-1 can replicate in macrophages.  Our working 90 
hypothesis is that mouse macrophages interact with, take up, and respond to ATCV-1 in 91 
a manner consistent with their potential role in cognitive impairments. Therefore, we 92 
challenged the mouse macrophage cell line RAW264.7 and primary inflammatory 93 
macrophages from C57Bl/6 mice with ATCV-1 and monitored infectivity and anti-viral 94 
responses of macrophages.  For comparison we challenged the BHK-21 fibroblast cell 95 
line with ATCV-1 and we challenged RAW264.7 cells with chloroviruses PBCV-1 and 96 
CVM-1, which are NC64A and Pbi viruses, respectively. 97 
 98 
MATERIALS AND METHODS 99 
Cells, viruses, and reagents 100 
Female C57Bl/6 mice were obtained from Harlan Sprague Dawley (Bar Harbor, Maine). 101 
RAW264.7 cells and BHK-21 cells were originally obtained from the American Type 102 
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Culture Collection (Rockville, MD) and grown in DMEM cell culture medium (Invitrogen, 103 
Carlsbad, CA) containing 10% fetal bovine serum (FBS) (Invitrogen), and 50 μg/ml 104 
gentamycin (Invitrogen).  Inflammatory macrophages from C57Bl/6 mice were elicited 105 
by i.p. injection of 2 ml sterile thioglycollate broth into mice (15). Three days later, the 106 
peritoneal cavities were flushed with 2 ml DMEM and cells were incubated at 106 cells/2 107 
ml of DMEM.  After 24 h, non-adherent cells were removed and 1 ml of DMEM added. 108 
Adherent peritoneal exudate cells (PECs) were greater than 90% Mac-1+ as determined 109 
by FACS analysis and were thus inflammatory macrophages (16).  110 
Virus ATCV-1 was grown in C. heliozoae SAG 3.83 cells, purified by successive 111 
rounds of gradient centrifugation,1% Triton-X 100  and proteinase K treatments  as 112 
previously described (17)  with some modifications: due to the sensitivity of ATCV-1 113 
virus to sucrose, two iodixanol gradient centrifugations were substituted for the sucrose 114 
gradients. For additional purification of ATCV-1 to remove any extraneous co-purifying 115 
proteins, an extra proteinase K with 1% Triton-X 100 treatment was added followed by a 116 
third iodixanol gradient centrifugation.  Consequently, the ultra-purification procedure 117 
resulted in two proteinase treatments and three iodixanol gradient centrifugations.  118 
PBCV-1 and CVM-1 chlorella virus were grown in Chlorella variabilis strain NC64A and 119 
Micractinium conductrix Pbi, respectively, and purified as decribed previously (17).  120 
Stock preparations were maintained in virus stabilization buffer (VSB: 10 mM Tris-HCl, 121 
50 mM MgCl2, pH 7.8) at 1x1011 plaque-forming units (PFU)/ml, then exchanged with 122 
phosphate buffered saline (PBS) at 1x1010 PFU/ml at the time of use. In one experiment 123 
virus was inactivated by heat treatment at 85oC for 5 min.  The ERK MAPK inhibitor 124 
U0126 was obtained from Promega Corporation (Madison, WI) and for some 125 
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experiments U0126 was added to RAW264.7 cells at 40 μM for 30 min prior to 126 
challenge with ATCV-1. 127 
Macrophage challenge with chlorovirus 128 
RAW264.7 cells or thioglycollate induced inflammatory macrophages from C57Bl/6 mice 129 
were incubated overnight at 37oC in DMEM at 5x105  cells/ml or 1x106 cells/ml, 130 
respectively. After overnight incubation, non-adherent cells were removed and the 131 
adherent cells were exposed to 1 μl of ATCV-1 containing 107 PFU. After 1 h 132 
incubation, the non-adsorbed ATCV-1 was aspirated off and 1 ml of fresh DMEM was 133 
added.  Culture supernatants and cellular lysates for RNA and protein analyses were 134 
obtained from samples at 0.5 to 72 h after challenge with ATCV-1.  Nitric oxide in 135 
culture supernatants from ATCV-1-challenged macrophages was quantified using a 136 
Greiss reagent kit from Invitrogen.  To evaluate the state of virus-mediated programmed 137 
cell death, ATCV-1-challenged macrophages were stained with AlexaFluor647 Annexin 138 
V (Invitrogen) plus propidium iodide, then fluorescence-activated cell scanning (FACS) 139 
analyzed using a Becton Dickinson FACSCalibur; the data were analyzed using FlowJo 140 
software (Treestar, Ashland, OR). To evaluate intracellular ATCV-1, ATCV-1 was 141 
incubated with Sytox-orange (Invitrogen), washed with PBS, and then suspended in 142 
PBS at 1010 PFU/ml.  RAW264.7 cells in culture were challenged with 107 stained-143 
ATCV-1 for 1 h, after which excess stained ATCV-1 was removed and the adherent 144 
RAW264.7 cells incubated for 24 h at 37 oC.  Following the incubation, the medium was 145 
removed, the cells were washed in PBS, and fixed in 4% paraformaldehyde/PBS and 146 
stained with CellMask™ plasma membrane stain immediately prior to confocal 147 
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microscopy. Localization of stained ATCV-1 was analyzed by the Kalman protocol for 148 
confocal microscopy  149 
 150 
Enumeration of ATCV-1 PFUs 151 
Culture supernatant fractions from macrophages challenged with ATCV-1 were 152 
removed and set aside after 1, 24, 48, and 72 h, and macrophages were lysed with 1% 153 
Triton X-100 in PBS.  The culture supernatants and lysates were combined and 154 
assessed for PFU using lawns of C. heliozoae cells in agarose as previously described 155 
(18). 156 
 157 
RNA preparation and qRT-PCR 158 
RNA was extracted from ATCV-1-challenged macrophage cells using the Purelink total 159 
RNA kit from Ambion/Invitrogen (Carlsbad, CA), according to the manufacturer’s 160 
specifications. One hundred ng to one μg of RNA was reverse transcribed in 0.5 mM 161 
each of dATP, dGTP, dTTP, and dCTP, 20 U of RNAse inhibitor with EasyScript 162 
reverse transcriptase (Lambda Biotech) at 42 oC for 50 min followed by 85 oC for 5 min. 163 
The cDNA was diluted 1:2 and one μl was incubated with 0.4 µM of the following primer 164 
pairs designed for mouse genes (Invitrogen): IFN-β sense 5’ 165 
ATGAACAACAGGTGGATCCTCC 3’ and anti-sense 5’ AGGAGCTC CTGACATTT 166 
CCGAA3’; IL-6 sense 5’ ATGAAGTTC CTCTCT GCAAGAGACT 3’ and antisense 5’ 167 
CACTAGGTTTG CCG AGT AGATCTC 3’; IRF7 sense 5’ CCAGCGAG 168 
TGCTGTTTGGAGAC 3’ and antisense 5’ TTCCCTAT TTTCCGTGGCTGGG 3’; iNOS 169 
sense 5’ CCCTTCCGA AGTTTCTG GCAGCAGC 3’ and antisense 5’ 170 
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GGCTGTCAGAGCCTCGTGGCTTTGG 3’; or GAPDH sense 5’-TTGTCAGCAAT 171 
GCATCCTGCAC-3’ and antisense 5’-ACAGCTTTCC AGAGGG GCCATC-3’.  ACTV-1 172 
major capsid protein (gene z280l) mRNA levels were evaluated by qRT-PCR with the 173 
primer pairs:  sense 5’ATGGCCGGAGGACTTTCACAGC 3’ and antisense 5’ 174 
AACGGAACCG TTGATGGTCTGC 3. Quantitative (q) PCRs were run on an ABI Prism 175 
7000 thermal cycler at 50 oC for 2 min, 95 oC for 10 min, 45 cycles of 95 oC for 15 s/60 176 
oC for 30 s. Cycle thresholds (CT) of sample were normalized to the CT of GAPDH for 177 
that sample (CT) and then normalized to the average CT of the control samples (CT), 178 
after which data were expressed as relative levels of mRNA using 2ΔΔCT.  179 
 180 
FACS Analysis  181 
RAW 264.7 cells were challenged with ATCV-1 at 20 multiplicity of infection (MOI) 182 
based on algal cell cultures and then incubated at 37 oC. After 1 h, non-adsorbed ATCV-183 
1 was removed and fresh cell culture medium was added.  After 48 h, cells were 184 
harvested and washed in cold PBS, re-suspended in Annexin V binding buffer, counted 185 
with a hemacytometer, and adjusted to 1x106/ml, after which 5 μl of AlexaFluor647-186 
conjugated Annexin V (Invitrogen) was added, followed by 0.4 μg/ml propidium iodide.  187 
All samples were analyzed using a Becton Dickinson FACSCalibur and the data were 188 
analyzed using FlowJo software. 189 
 190 
PAGE and western blot analysis 191 
Cell protein lysates were obtained from RAW264.7 cells challenged with ATCV-1 at 30 192 
min for up to 72 h. Twenty μl of each lysate, in sample buffer with bromophenol blue, 193 
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were electrophoresed on a 10% SDS–Tris-glycine-polyacrylamide gel (SDS-PAGE) and 194 
transferred to a nitrocellulose membrane. The membrane was treated with LI-COR 195 
(Lincoln, NE) blocking buffer containing fish gelatin for 1 h at room temperature, 196 
followed by incubation in a 1:700 dilution of rabbit anti-ATCV-1 IgG, a 1:1000 dilution of 197 
mouse anti-phospho-ERK (Cell Signaling, Beverly, MA), a 1:1000 dilution of rabbit anti-198 
ERK (Cell Signaling), a 1:1000 dilution of rabbit anti-cleaved-caspase 3 (Cell Signaling) 199 
or 2 μg/ml mouse anti-tubulin antibodies (Invitrogen). These primary antibodies were 200 
revealed with either a 1:5000 dilution of IRDye 800CW goat anti-rabbit IgG (Rockland 201 
Immunochemicals, Inc., Gilbertsville, PA) or Alexa Fluor 680-labeled anti-mouse IgG 202 
(Rockland). The washed membrane was scanned with a LI-COR Odyssey (Lincoln, NE) 203 
infrared imaging system.    204 
  205 
IL-6 protein quantification 206 
To quantify IL-6 in culture supernatants of macrophages challenged with ATCV-1, 207 
ELISA plates were coated with 1 μg/ml antibodies to mouse IL-6 (MP5-20F3) (BD 208 
Biosciences, San Jose, CA); the plates were blocked with PBS/10% FBS. After washes, 209 
cell culture supernatants or serial dilutions of recombinant IL-6 were added to the wells. 210 
After 2 h, one μg/ml biotinylated antibody to mouse IL-6 (MP5-32C11) was added to 211 
each well. After 1 h, streptavidin conjugated to horseradish peroxidase (1:1000) was 212 
added for 30 min and then tetramethylbenzidine substrate/hydrogen peroxide solution 213 
was added to each well. All ELISA reagents were purchased from BD-Pharmingen (BD 214 
Biosciences, San Jose, CA). IL-6 was measured by determining optical densities at 450 215 
nm wavelength with reference wavelength 570 nm. 216 
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 217 
Statistical analysis  218 
Where appropriate, data were analyzed by ANOVA and the Student's t test to determine 219 
the significance of differences between the sample means. P values of less than 0.05 220 
were considered to be significant. 221 
 222 
RESULTS 223 
ATCV-1 was taken up by and persisted within macrophages 224 
Because DNA sequences resembling chlorovirus ATCV-1 were found in human 225 
oropharyngeal tissues and ATCV-1 inoculation of mice increased expression of several 226 
pro-inflammatory genes within the hippocampus (4), we examined the response of 227 
RAW264.7 mouse macrophage and primary inflammatory mouse macrophage cells to 228 
challenge with purified ATCV-1.  For comparison, we also challenged BHK-21 cells, a 229 
hamster kidney fibroblast cell line, with ATCV-1. In addition, we challenged RAW264.7 230 
cells with the chloroviruses PBCV-1 (NC64A type) and CVM-1 (Pbi type).  The viruses 231 
were allowed to adsorb for 1 h onto seeded RAW264.7, primary macrophages, or BHK-232 
21 cells.  Following this initial incubation, the medium was aspirated to remove non-233 
absorbed virus, and replaced with 1 ml of cell culture medium.  After 24 and 72 h, cells 234 
were examined microscopically for cytopathic effects.  RAW264.7 cells challenged with 235 
ATCV-1 showed notable signs of cell stress at 24 h that included membrane blebbing,  236 
nuclear fragmentation, and some cell death (Fig. 1A); in contrast, very few cells with 237 
cytopathic effects were seen in mock treated cells or in RAW264.6 cells challenged with 238 
either PBCV-1 or CVM-1 (data not shown).   Inflammatory macrophages did not exhibit 239 
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significant cell death by 72 h (Fig. 2A).  However, inflammatory macrophages 240 
challenged with ATCV-1 exhibited prominent dendritic cellular projections compared 241 
with mock infected cells.   242 
In parallel experiments, after non-adsorbed virus was removed at 1 h, ATCV-1 243 
and CVM-1 in cells and culture supernatants were quantified for PFUs on algal C. 244 
heliozoae SAG 3.83 cells or Micractinium conductrix cells, respectively, starting at 1 h 245 
through 72 h post challenge.  In four separate experiments with 5 replicates for each 246 
time point, on average 8% of the initial inoculum or 0.8 x 106 PFU/culture were cell 247 
associated at 1 h (Fig. 1B). By 24 h ATCV-1 PFU increased further to an average of 2.6 248 
x 106 PFU/culture declining slightly to 1.9 x 106 PFU/culture by 72 h.  Comparing the 1 h 249 
PFU with the remainder of the time points, significantly higher amounts of ATCV-1 PFU 250 
were seen at 24 to 72 h (n=20; F=10.6; p=0.00001) (Fig. 1B).  Therefore, ATCV-1 251 
persisted and appeared to replicate in the RAW264.7 macrophage cell line.  In contrast 252 
to ATCV-1, an average of 1 x 104 PFU or 0.1% of the initial CVM-1 inoculum was 253 
associated with RAW264.7 cells at 1 h (Fig. 1D). The level of CVM-1 in RAW264.7 cells 254 
declined at 24 h to an average of 5.6 x 103 PFU/culture and declined further to 2.6 x 103 255 
PFU/culture by 72 h.  Thus ATCV-1 virus persisted and possibly replicated in 256 
RAW264.7 cells while CVM-1 virus did not.   257 
ATCV-1 that associated with primary mouse inflammatory macrophages (PECs) 258 
at 1 h was 2.7 x 105 PFU/culture or 2.7% of the initial inoculum (Fig. 2B).  The level of 259 
ATCV-1 PFU increased at 24 h to 3.9x105 and again at 72 h to an average of 5.0 x 260 
105/culture.  There was a significant increase in ATCV-1 PFUs at 72 h compared with 261 
48 h (p=0.00001).  In contrast to macrophages, BHK-21 cells challenged with MOI = 20 262 
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ATCV-1 PFU exhibited very low number of PFUs that were cell-associated from 1 to 72 263 
h post challenge (Fig. 2D).  On average only 41 to 49 ATCV-1 PFUs were detected in 264 
BHK-21 per cell culture from 1- 72 h post challenge. To determine if ATCV-1 RNA was 265 
expressed in RAW264.7 and PEC macrophages that were challenged with ATCV-1, 266 
total RNA was isolated, and mRNA for the ATCV-1 major capsid protein (gene z280l) 267 
was measured by qPCR methods.  Both RAW264.7 and PEC macrophages expressed 268 
ATCV-1 major capsid protein mRNA starting at 24 h through 72 h post challenge (Fig. 269 
2C).  On average 40 copies of major capsid protein mRNA at 24 h, 139 copies at 48 h, 270 
and 100 copies at 72 h were detected per RAW264.7 cell culture.   271 
To determine if ATCV-1 was internalized by RAW264.7 cells and not simply 272 
attached to the cell surface, we stained ATCV-1 with Sytox-orange prior to challenge of 273 
cells and then evaluated them in the RAW264.7 cells using confocal microscopy at 24 274 
h.  Sytox-orange-stained ATCV-1 was equally as infectious to C. heliozoae SAG 3.83 275 
cells as non-stained ATCV-1, indicating the stain had no effect on virus infectivity in 276 
algae (Dunigan, unpublished results).  No intracellular fluorescence occurred in control 277 
RAW264.7 cells, whereas cells challenged with stained ATCV-1 clearly exhibited cell 278 
associated punctate fluorescence consistent with virus association (Fig. 3A).  To further 279 
examine the interaction of RAW264.7 cells with ATCV-1 PFU, we challenged 280 
RAW264.7 cells with Sytox-orange-stained ATCV-1 and after 24 h stained the cells with 281 
CellMask™ plasma membrane stain prior to confocal microscopy and intracellular virus 282 
was identified using the Kalman protocol for confocal microscopy.  In this case, Sytox-283 
orange stained virus was seen intracellularly within and beyond the blue plasma 284 
membrane stain in RAW264.7 cells (Fig. 3B). 285 
  
14
 286 
ATCV-1 proteins were produced in RAW264.7 cells 287 
Antiserum to purified ATCV-1 was generated in rabbits following a series of immunizing 288 
injections. Using western blots after applying 108 ATCV-1 PFU equivalents to PAGE 289 
gels, rabbit anti-ATCV-1 serum reacted with at least 23 distinct proteins (data not 290 
shown).  To determine if ATCV-1 proteins could be detected in RAW264.7 cells 291 
following challenge with ATCV-1, protein lysates generated from 16 to 66 h post 292 
challenge were evaluated by western blots using the rabbit anti-ATCV-1 serum.  A 293 
constant level of a 55 kDa protein similar in size to the ATCV-1 major capsid protein 294 
was detected in cellular lysates from RAW264.7 cells from 16 to 66 h post challenge, 295 
but not in lysates from mock-challenged cells (Fig. 4A).  In addition, a 17 kDa protein 296 
appeared at 16 h and its intensity increased from 48 to 66 h post challenge.  No other 297 
anti-ATCV-1 IgG-binding proteins were detected. To determine if these two proteins 298 
were from phagocytosis of the original ATCV-1 inoculum or generated during viral 299 
challenge, RAW264.7 cells were challenged with either infectious or heat-inactivated 300 
ATCV-1.  Western blot of protein lysates from cells at 24 to 72 h post challenge 301 
revealed that nearly equal levels of the 55 kDa protein were detected at 24 h in 302 
RAW264.7 cells challenged with either infectious or heat-inactivated ATCV-1 (Fig. 4B).  303 
However, at 48 and 72 h the intensity of the 55 kDa protein declined in RAW264.7 cells 304 
challenged with heat-inactivated ATCV-1.   Moreover, the 17 kDa protein, which 305 
appeared in cells challenged with infectious ATCV-1, did not appear at any time in 306 
RAW264.7 cells following challenge with heat-inactivated ATCV-1.  More importantly, 307 
the RAW264.7 cells did not exhibit a cytopathic effect  (Fig. 4C).  Therefore, two ATCV-308 
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1 antisera-reacting proteins were detected in RAW264.7 cells challenged with ATCV-1 309 
virus and infectious particles were apparently required to sustain expression of these 310 
two proteins.  It is not known if other ATCV-1 proteins were expressed in RAW264.7 311 
cells but were not produced at a detectable level or were not recognized with the rabbit 312 
antisera used in this experiment. 313 
 314 
ATCV-1 activated programmed cell death in RAW264.7 cells 315 
RAW264.7 cells challenged with infectious ATCV-1 exhibited cytopathic effect and/or 316 
died by 72 h.  Virus-activated apoptosis is a key antiviral mechanism that limits viral 317 
replication (19) but could also contribute to viral persistence through macrophage 318 
phagocytosis of apoptotic virus-infected cells(20).  Cleavage of caspase 3 (21) and 319 
binding of Annexin V to phosphatidylserine at the cell membrane (22) are hallmarks of 320 
apoptotic cell death.  To determine if RAW264.7 cells challenged with ATCV-1 undergo 321 
apoptosis, cells were stained with Annexin V at 48 h and cell extracts were analyzed by 322 
western blot for cleaved-caspase 3 at 24 h post challenge.  RAW264.7 cells challenged 323 
with ATCV-1 at a MOI=20 PFU/cell exhibited a significant increase in cleaved-caspase 324 
3 at 24 h (Fig. 5A) and robust Annexin V staining at 48 h post challenge (Fig. 5B).  325 
Therefore, RAW264.7 cells challenged with ATCV-1 appear to undergo apoptotic 326 
programmed cell death, which may be an antiviral mechanism that limits virus 327 
replication. 328 
 329 
ATCV-1 activation of ERK MAP-kinases may contribute to apoptosis in RAW264.7 330 
cells 331 
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The MAP kinase ERK is involved in apoptotic programmed cell death in response to 332 
DNA damaging agents, but also in response to interferon-α (IFN-α) (23).  Therefore, we 333 
evaluated ATCV-1-challenged RAW264.7 cells for ERK activation using phospho-334 
specific antibodies in western blots.  RAW264.7 cells challenged with ATCV-1 formed 335 
phospho-ERK as early as 30 min post challenge that was still present at 60 min, but 336 
absent at 3 h post challenge (Fig. 6A).  A specific inhibitor of ERK activation U0126 was 337 
used to pretreat RAW264.7 cells during challenge with ATCV-1 to determine if ERK 338 
activation was associated with ATCV-1-induced cell death.  Treatment of RAW264.7 339 
cells with 40 μM U0126 during ATCV-1 challenge inhibited ERK activation (Fig. 6B).  340 
Moreover, U0126 prevented ATCV-1-mediated cytopathic effect and death of 341 
RAW264.7 cells (Fig. 6C). Therefore, ERK MAP kinases appear to be involved in 342 
ATCV-1-induced cytopathic effect of RAW264.7 macrophages. 343 
 344 
ATCV-1 induced innate antiviral immune responses in macrophages 345 
A hallmark of viral infection of mammalian cells is the rapid induction of IFN-β and 346 
interferon-response genes (ISGs), such as IRF7 (24).  To determine if RAW264.7 cells 347 
and primary inflammatory macrophages underwent antiviral responses, both IFN-β and 348 
IRF7 expression was evaluated post ATCV-1 challenge using qRT-PCR.  RAW264.7 349 
cells and inflammatory macrophages expressed IFN- β at 72 h and IRF7 by 24 h post 350 
challenge with ATCV-1 (Fig. 7 A, B).  RAW264.7 cells challenged with chlorovirus 351 
CVM-1 did not respond with any expression of IFN-β or IRF7 mRNA (data not shown). 352 
Therefore macrophages challenged with ATCV-1 appear to undergo some aspects of a 353 
canonical innate antiviral response (25). 354 
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 355 
ATCV-1 induced responses in macrophages consistent with shift towards 356 
inflammatory phenotype 357 
In addition to ISGs, macrophages challenged with viruses also express inflammatory 358 
cytokines such as IL-6 and inflammatory factors such as NO, both of which have 359 
antiviral effects, and are also involved in neurological memory impairments (12). 360 
Therefore we evaluated IL-6 inducible nitric oxide synthase (iNOS) and NO production 361 
from RAW264.7 cells and inflammatory macrophages after either mock or ATCV-1 362 
challenge.  While RAW264.7 cells expressed much higher levels of IL-6 mRNA starting 363 
at 24 h post challenge (Fig. 7C), both cell types produced similar levels of IL-6 protein 364 
within 24 h post challenge with ATCV-1 (Fig. 7 D).  RAW264.7 cells challenged with 365 
chlorovirus CVM-1 did not respond with expression of IL-6 mRNA (data not shown). 366 
Likewise RAW264.7 cells responding to ATCV-1 expressed iNOS and produced NO 367 
within 24 h post ATCV-1 challenge (Fig. 8A, B).  In contrast, expression of iNOS from 368 
primary inflammatory macrophages did not occur until 72 h post challenge with ATCV-1.    369 
Nevertheless, macrophages interacting with ATCV-1 expressed inflammatory factors, 370 
many of which are linked to memory impairments and mental illnesses (14, 26, 27).  371 
The plasticity of macrophage phenotypes have been noted to take place in 372 
response to microbial challenge (28, 29) .  One of the phenotypes consistent with 373 
inflammatory macrophages results in a metabolic change such that glycolysis is 374 
enhanced and oxidative phosphorylation is reduced (30). This aerobic glycolysis results 375 
in rapid ATP formation with increased production of lactic acid.  To determine if 376 
RAW264.7 cells and PEC macrophages exhibit an inflammatory macrophage 377 
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phenotype following challenge with ATCV-1, we measured lactate in the culture 378 
supernatants.  Both RAW264.7 cells (Fig. 8C) and PEC macrophages (Fig. 8D) that 379 
were unchallenged produced slight amounts of lactate over time.  However, challenge 380 
of both RAW264.7 cells and PEC macrophages with ATCV-1 significantly elevated 381 
lactate production into the cell culture medium starting at 24 h post challenge with 382 
increasing levels at 48 and 72 h relative to mock-challenged cells.         383 
 384 
DISCUSSION 385 
The results of the present investigation show that macrophages challenged with the 386 
Chlorovirus ATCV-1 took up the virus, maintained and possibly replicated infectious 387 
units of it, and underwent responses that included apoptosis, morphological changes, 388 
and production of inflammatory factors. The data show with both RAW264.7 cells and 389 
peritoneal macrophages that ATCV-1 PFUs increased from 24 h to 72 h post challenge.  390 
This suggests that a small but significant amount of viral replication possibly took place 391 
in macrophages challenged with ATCV-1.  Another cell type, BHK-21, which is a 392 
fibroblastic cell line that supports replication of several virus types (31, 32), did not 393 
maintain ATCV-1 to any extent and did not exhibit any increase in ATCV-1 PFUs over 394 
the 72 h culture period.  Thus macrophages may be uniquely suited to maintain viruses 395 
that might infect them. For example,  Mimiviruses were shown to infect macrophages 396 
that phagocytized these giant viruses (33).  Moreover influenza viruses infected 397 
macrophages, either directly or through phagocytosis of apoptotic macrophages that 398 
were previously infected by influenza viruses (34).  In this case exposure of 399 
phosphatidylserine at the outer leaflet of the cell membrane was the basis for Annexin V 400 
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staining of apoptotic cells and was a key feature of apoptotic cells assuring their 401 
phagocytosis by macrophages.  Moreover, viral apoptotic mimicry by enveloped viruses 402 
through exposure of phosphatidylserine at their envelop is a well-known mechanism for 403 
viral persistence (20).  We show here that ATCV-1 infected RAW264.7 cell exhibit 404 
robust Annexin V staining at 48 h post challenge.  Therefore, viral replication 405 
notwithstanding, it is likely that phagocytosis of apoptotic macrophages induced by 406 
ATCV-1 contributed significantly to the maintenance of ATCV-1 in macrophage 407 
populations.  408 
In addition to induction of apoptosis in macrophages, the macrophage responses 409 
to ATCV-1 are significant because they included production of inflammatory factors by 410 
these cells that have been linked to memory impairments, which occur in mice exposed 411 
to ATCV-1 (4).  One of the inflammatory factors produced in response to ATCV-1 is IL-6 412 
and its production was induced quickly after challenge with ATCV-1. The data indicated 413 
that most of the accumulation of IL-6 has occurred within 24 h after ATCV-1 challenge. 414 
An interesting aspect of our data is the discrepancy between the amount of IL-6 415 
produced and the relative level of IL-6 mRNA expression. This is likely due to the fact 416 
that IL-6 production was controlled posttranscriptionally whereby IL-6 mRNA was rapidly 417 
degraded (35). As a result production of IL-6 and expression of IL-6 mRNA were not 418 
always correlated.  Nevertheless it is noteworthy that macrophages respond to ATCV-1 419 
with robust IL-6 production, an inflammatory cytokine that causes neurological 420 
impairments.  It is known that during several different types of viral infections 421 
macrophages take up virions, migrate to various anatomical locations, including the 422 
CNS, and respond to the viruses by producing inflammatory factors (36).  The results 423 
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here indicate that macrophages could be a host cell that retains ATCV-1 without 424 
destroying the virus and responds to the virus with the production of inflammatory 425 
factors.  Increased levels of pro-inflammatory cytokines are associated with cognitive 426 
impairments in a number of human disorders including Alzheimer’s disease (37), 427 
cognitive decline in the elderly (38), stroke (39), and psychiatric disorders (40). However, 428 
it remains to be seen if ATCV-1 infects and induces responses in other cell types of the 429 
CNS such as neurons and astrocytes. Moreover, it would not be surprising if brain 430 
microglial cells, which are of the macrophage lineage, take up and respond to ATCV-1 431 
with production of inflammatory mediators. 432 
We also show here that macrophages contained a significant number of 433 
infectious ATCV-1 PFU for at least 72 h post challenge and two ATCV-1 proteins 434 
appeared to be produced within the macrophages to a degree that was detected by 435 
western immunoblot. A 55 kDa protein consistent with the size of the major capsid 436 
protein and a 17 kDa protein of unknown identity were produced by RAW264.7 cells 437 
challenged with ATCV-1.  When heat-inactivated ATCV-1 was used to challenge the 438 
RAW264.7 cell line, the 55 kDa protein was detected by western blot for the first 24 h 439 
post infection; however, the level of this protein declined after 24 h.  This result 440 
suggested that some of the 55 kDa protein detected with infectious ATCV-1 was 441 
probably from phagocytosed virus particles but some of the 55 kDa protein was likely 442 
synthesized de novo. In contrast, the unknown 17 kDa protein(s) was not detected at 443 
any time when RAW264.7 cells were challenged with heat-inactivated ATCV-1.  The 444 
level of this same protein(s) increased with time after 24 h post challenge with 445 
infectious-ATCV-1.  These observations suggest that the 17 kDa protein(s) that reacts 446 
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with ATCV-1 antiserum was synthesized de novo in RAW264.7 cells challenged with 447 
ATCV-1. It is likely that other immunoreactive ATCV-1 proteins were synthesized but 448 
not detected because they were not produced to a sufficient level in RAW264.7 cells.  449 
When purified ATCV-1 virus (108 viral particles that were heat inactivated and 450 
denatured) was electrophoresed on a polyacrylamide gel and rabbit anti-ATCV-1 sera 451 
were used in western blots, 23 distinct proteins were detected (data not shown).  452 
However, there were only 5 x 104 PFUs in ATCV-1 challenged RAW264.7 cells at 72 h 453 
(Fig. 1B).  We conclude that the rabbit anti-ATCV-1 sera would not detect most of these 454 
protein unless a threshold of viral particle equivalents is reached, ie. 106 or 107.  Further 455 
analyses, beyond the scope of this study, are required to determine the origin of these 456 
proteins, i.e., either host or virus. 457 
Another feature of the ATCV-1 challenge of macrophages was a shift in 458 
metabolism in these cells towards aerobic glycolysis.  ATCV-1 induced lactate 459 
production from both RAW 264.7 cells and PECs. The increased lactate production is 460 
likely due to establishment of a macrophage phenotype consistent with M1 461 
macrophages, which are pivotal to host defense but also to inflammation (29, 30, 41).   462 
During this shift in metabolism, oxidative phosphorylation in the mitochondria is 463 
disrupted and glycolysis is enhanced.  Moreover, it is unclear if the shift in metabolism 464 
was initiated by ATCV-1 factors or if it was a response to activation of innate antiviral 465 
pathways.  Several reports indicate that activation of Toll-like receptor (TLR) pathways 466 
triggers the shift in macrophage and dendritic cell metabolism towards glycolysis and 467 
away from oxidative phosphorylation (30, 42).  As a result of this shift pyruvate is 468 
preferentially converted to lactate rather than entry into the TCA cycle.  Another feature 469 
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of this shift in metabolism is increased production of NO, which not only impairs 470 
mitochondrial activity, but which also has antiviral activity (43).  The response of 471 
macrophages to ATCV-1 challenge was a robust production of NO.  It remains to be 472 
seen if the enhanced production of lactate and NO by macrophages plays any role in 473 
the learning impairments associated with ATCV-1 challenge in mice (4) or plays any 474 
role in anti-viral activity of macrophages.  Nitric oxide is a gaseous cell signaling 475 
molecule produced by NO synthases and activates an intracellular signaling enzyme 476 
guanylate cyclase (44). While NO is needed by the central nervous system, excess NO 477 
is associated with CNS impairments (45). Moreover, there is evidence for activation of 478 
microglia, which is part of the macrophage cell lineage, and an increase in iNOS 479 
expression in both a rat model for schizophrenia (27) and in patients with schizophrenia 480 
(46).  Numerous studies report elevated NO production occurs in Alzheimer’s disease, 481 
multiple sclerosis, and Parkinson’s disease (47 48). Therefore, because macrophages 482 
retained and responded to ATCV-1, in addition to their migratory properties in response 483 
to inflammation, it is possible that macrophages encountering ATCV-1 could initiate 484 
responses detrimental to memory formation. 485 
In addition to inducing a shift in metabolism, RAW264.7 cells challenged with 486 
ATCV-1 initiated apoptotic programmed cell death, as evidenced by increased 487 
production of cleaved-caspase 3 and Annexin V staining.  Our data suggest that rapid 488 
activation of ERK MAP kinases may contribute to the activation of apoptotic death.  489 
Addition of the ERK MAP kinase inhibitor U0126 prevented cell death of RAW cells in 490 
the presence of ATCV-1.  Other reports show the involvement of ERK MAP kinase in 491 
activation of apoptosis of cells in response to DNA damaging agents (49) and type I 492 
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interferons (23).  The mechanism by which ATCV-1 induces activation of ERK MAP 493 
kinases or apoptotic programmed cell death is unknown.  494 
In summary, Chlorovirus ATCV-1, a SAG virus that infects the alga C. heliozoae 495 
an endosymbiont of the heliozoon Acanthocystis turfacea, induced powerful 496 
inflammatory responses from mouse macrophages that included a shift in metabolism 497 
towards aerobic glycolysis with production of lactate, NO and IL-6.  Moreover, infectious 498 
ATCV-1 virions were retained within the macrophages and ATCV-1 proteins were 499 
produced by the inoculated mouse macrophage cell line RAW264.7.  Moreover, a low 500 
level ATCV-1 replication appeared to occurr in RAW264.7 cells.  Ultimately ATCV-1 501 
activated apoptotic programmed cell death in RAW264.7 cells.  Therefore, the 502 
hypothesis that ATCV-1 could be sustained and replicate within and trigger 503 
neuroinflammatory responses using a macrophage cellular host remains valid.  504 
However, it remains to be determined if these pro-inflammatory responses induced by 505 
ATCV-1 from macrophages play a role in previously described CNS memory 506 
impairments associated with ATCV-1 in both humans and mice (4).   507 
 508 
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 717 
FIG. 1.  Chlorovirus ATCV-1 was taken up by and persisted within the RAW 264.7 718 
macrophage cell line.  5x105 RAW264.7 cells grown in culture medium overnight were 719 
challenged with 1x107 ATCV-1 PFU for 1 h, after which the culture medium containing 720 
non-adsorbed ATCV-1 PFUs was removed and fresh culture medium was added to the 721 
cells.  (A) After 24 and 72 h, microscopic differential interference contrast (DIC) images 722 
of RAW264.7 cell cultures were taken at 400x magnification; vertical panels represent 3 723 
regions of the cell culture field.  (B) After 1, 24, 48, and 72 h PFUs in cell extracts plus 724 
culture supernatants were assessed by viral plaque assays using C. heliozoae cell 725 
cultures, data were from 4 separate experiments with 5 replicates/time point for each 726 
experiment, n=20; (C) PFUs in cell extracts plus culture supernatants from CVM-1 727 
inoculated cells were assessed by viral plaque assays using Micractinium conductrix 728 
cell cultures, n=5/time point. Values are means + standard error..   729 
 730 
FIG. 2.   Chlorovirus ATCV-1 was taken up and persisted within inflammatory peritoneal 731 
exudate macrophage cells (PECs) but not BHK-21 cells.  5x105 RAW264.7 cells, 1x106 732 
PEC cells, and 1 x 106 BHK-21 cells grown in culture medium overnight were 733 
challenged with 1x107 ATCV-1 PFU for 1 h, after which the culture medium containing 734 
non-adsorbed ATCV-1 PFU was removed, and fresh culture medium was added.  (A) 735 
After 24 and 72 h, microscopic DIC images of PEC cell cultures were taken at 400x.  736 
Vertical panels represent 3 regions of the cell culture field.  (B) After 1, 24, 48, and 72 h, 737 
PFUs in PEC extracts plus culture supernatants were assessed by viral plaque assays 738 
using C.heliozoae cell cultures. (C) After 24, 48, and 72 h RNA was extracted for qRT-739 
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PCR of ATCV-1 major capsid protein (gene z280l) mRNA expression. (D) After 1, 24, 740 
48, and 72 h, PFUs in BHK-21 extracts plus culture supernatants were assessed by 741 
viral plaque assays. Values are means + standard error, n=5. * indicates significantly 742 
different than values at 48 h. 743 
 744 
FIG. 3.  ATCV-1 virions appeared to be intracellular in RAW264.7 cells 24 h post 745 
challenge.  Purified ATCV-1 was incubated with Sytox Orange for 1 h, after which 746 
virions were washed twice in PBS and used to challenge RAW cells.  5x105 RAW cells 747 
grown in culture medium overnight were challenged with 1x107 stained ATCV-1 PFU for 748 
1 h, after which the culture medium and non-adsorbed ATCV-1 PFU were removed, and 749 
fresh culture medium was added. After 24 h RAW264.7 cells were (A) imaged with 750 
fluorescence microscopy or (B) washed once in cell culture media, fixed in 4% 751 
paraformaldehyde, and membrane stained with CellMask™ plasma membrane stain. 752 
Panel A represents cells imaged with DIC and fluorescence; panel B represents cells 753 
imaged by confocal microscopy with intracellular ATCV-1 identified using the Klaman 754 
protocol for confocal microscopy.   755 
 756 
FIG. 4.  Chlorovirus ATCV-1 proteins were expressed within RAW 264.7 cells 757 
challenged with infectious ATCV-1.  5x105 RAW cells grown in culture medium 758 
overnight were challenged with 1x107 infectious ATCV-1 PFU or heat-inactivated ATCV-759 
1 for 1 h, after which culture medium and non-adsorbed ATCV-1 PFU were removed, 760 
and fresh culture medium was added.  (A) Immunoblot of cell lysates 16, 24, 48, and 66 761 
h after challenge with infectious ATCV-1 using rabbit anti-ATCV-1 serum; (B) 762 
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immunoblot of cell lysates 24, 48, and 72 h after challenge with infectious or heat-763 
inactivated ATCV-1(85oC for 5 min); (C) after 72 h following challenge with infectious or 764 
heat-inactivated ATCV-1, microscopic images of RAW264.7 cell cultures were taken at 765 
400x magnification.   766 
 767 
FIG. 5. Chlorovirus ATCV-1 induced apoptotic programmed cell death in RAW 264.7 768 
cells. 5x105 RAW26.7 cells grown in culture medium overnight were challenged with 769 
1x107 ATCV-1 PFU, after which culture medium and non-adsorbed ATCV-1 PFU were 770 
removed, and fresh culture medium was added.  (A) Immunoblot of cell lysates from 771 
one unchallenged RAW264.7 cell culture and three ATCV-1 challenged RAW264.7 cell 772 
cultures at 24 h using rabbit anti-cleaved-caspase3 and mouse anti-beta tubulin 773 
antibodies; (B) FACS analysis of propidium iodide and Annexin V staining at 48 h post 774 
challenge with ATCV-1.   775 
 776 
FIG. 6.  ERK MAP kinases were activated in RAW 264.7 cells challenged with infectious 777 
ATCV-1.  (A) 5x105 RAW264.7 cells grown in culture medium overnight were 778 
challenged with 1 x 107 ATCV-1 PFUs.  Immunoblot of RAW264.7 cell lysates 30, 60, 779 
180, and 360 min after challenge with infectious ATCV-1 using mouse anti-phospho 780 
ERK1/2 and rabbit anti-ERK1/2 antibodies;  (B, C) 5x105 RAW cells grown in culture 781 
medium overnight were treated with 40 μM U0126 for 30 min prior to challenge with 782 
1x107 infectious ATCV-1.  (B) Phospho-ERK immunoblot of RAW 264.7 cell lysates at 783 
30, 60, and 120 min and 48 h; (C) microscopic images of RAW264.7 cell cultures taken 784 
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at 400x magnification after 72h. Vertical panels represent 3 regions of the cell culture 785 
field. 786 
 787 
FIG. 7.  Chlorovirus ATCV-1 challenged RAW 264.7 cells and peritoneal exudate cell 788 
(PEC) macrophages expressed an antiviral response with inflammatory cytokine IL-6.  789 
5x105 RAW cells or 1 x 106 PEC macrophages grown in culture medium overnight were 790 
challenged with 1x107 ATCV-1 PFU for 1 h, after which culture medium and non-791 
adsorbed ATCV-1 PFU were removed, and fresh culture medium was added.  After 24, 792 
48, and 72 h RNA was extracted from cellular lysates and for qRT-PCR of (A) IFN-β; 793 
(B) IRF7; (C) IL-6 and culture supernatants were collected for ELISA of (D) IL-6 protein.  794 
Values are means + standard error, n=5.   795 
 796 
FIG. 8.  Chlorovirus ATCV-1 challenged RAW 264.7 cells and peritoneal exudate cell 797 
(PEC) macrophages expressed iNOS, nitric oxide and secreted elevated levels of 798 
lactate.  5x105 RAW cells or 1 x 106 PEC macrophages grown in culture medium 799 
overnight were challenged with 1x107 ATCV-1 PFU for 1 h, after which culture medium 800 
and non-adsorbed ATCV-1 PFU were removed, and fresh culture medium was added.  801 
After 24, 48, and 72 h RNA was extracted from cellular lysates and culture supernatants 802 
collected for (A) Greiss assay of nitric oxide; (B) qRT-PCR of iNOS; (C, D) secreted 803 
lactate assay.  Values are means + standard error, n=5.   804 
 805 
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